PCSK9 inhibitors: when statins aren't enough

This article examines the current approaches to lipid‐lowering for primary and secondary prevention of cardiovascular disease and the place of these new agents in therapy.

Source: Prescriber - October 23, 2017 Category: Primary Care Authors: Steve Chaplin Tags: Therapy Review Source Type: research